Skip to content

A Study on the effect of transnasal mask pre-oxygenation combined with apneic oxygenation on oxygenation in obese patients

A Study on the effect of transnasal mask pre-oxygenation combined with apneic oxygenation on oxygenation in obese patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089367
Enrollment
Unknown
Registered
2024-09-06
Start date
2024-04-25
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre-oxygenation combined with apneic oxygenation

Interventions

Mask pre-oxygenation group:Use a mask at 10 L/min for pre-oxygenation, and do not give oxygen during apnea.
High flow nasal cannula pre-oxygenation group:Use a high-flow nasal cannula at 30 L/min for pre-oxygenation, and do not give oxygen during apnea.
High-flow nasal cannula pre-oxygenation combined with apnea oxygenation group:Use high-flow nasal cannula 30 L/min for pre-oxygenation
use high-flow nasal cannula 60 L/min to provide oxygen during apnea.
Anesthesia-specific nasal mask pre-oxygenation group:Use an anesthesia-specific nasal mask 10L/min for pre-oxygenation, and no oxygen is given during apnea.
Anesthesia-specific nasal mask pre-oxygenation combined with apnea oxygenation group:Use an anesthesia-specific nasal mask Perform pre-oxygenation at 10 L/min, and use a special nasal mask for anesthe

Sponsors

Gansu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18-65 years 2.ASA grade I-II,BMI>28kg/m2 3.Elective surgery patients undergoing general anesthesia 4.Patients voluntarily participate in this study and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1) Chronic respiratory diseases; Uncontrolled hypertension; congestive heart failure; 2) Nasal congestion, nasal lesions 3) Pregnant women, anemia 4) Patients at high risk of aspiration (e.g. intestinal obstruction, etc.) 5) Patients who are unable to tolerate hypercapnia (pulmonary hypertension, neurological space-occupying lesions)

Design outcomes

Primary

MeasureTime frame
safe apnea time;Intraoperative adverse events (hypotension, arrhythmia, laryngospasm);Postoperative adverse events (nasal dryness and pain, pharynx dryness and pain, tinnitus, flatulence);End-tidal CO2 partial pressure;Hemodynamics:mean arterial pressure (MAP);partial pressure of arterial oxygen,arterial carbon dioxide partial pressure,PH;

Secondary

MeasureTime frame
Oxygen concentration under the sound gate;Gastric antrum ultrasound cross-sectional area.;

Countries

China

Contacts

Public ContactWenjun YAN

Gansu Provincial People's Hospital

13893370700@163.com+86 138 9337 0700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026